Flublok Quadrivalent Northern Hemisphere
Product Images NDC 49281-723

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Flublok Quadrivalent Northern Hemisphere (NDC 49281-723). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Vaccines Us Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.5 mL Syringe Label)

Packaging label for Flublok Quadrivalent Northern Hemisphere influenza vaccine by Sanofi Vaccines US Inc. The label shows the NDC 49281-722-88, specifies the 2022/2023 formula, single-dose 0.5 mL for intramuscular injection, no preservative, and manufacturing by Protein Sciences Corp. Two areas are reserved for lot and expiry information, which are blank in this image.*

FDA Label Image

Principal Display Panel (0.5 mL Syringe Carton)

Packaging label for Flublok Quadrivalent Influenza Vaccine 2022/2023 Formula by Sanofi Pasteur, distributed by Sanofi Vaccines US Inc. The product contains 10 single-dose prefilled syringes, each with 0.5 mL. It is indicated for intramuscular administration for individuals 18 years and older. The label includes storage instructions, formulation details, and manufacturer information.*

FDA Label Image

Principal Display Panel (0.5 mL Syringe Label)

Label for Flublok Quadrivalent Northern Hemisphere influenza vaccine, 2022/2023 formula, no preservative. The label indicates a single-dose (0.5 mL) for intramuscular injection, manufactured by Protein Sciences Corp., and includes space reserved for lot and expiry information. NDC 49281-722-88 is displayed along with a barcode and a QR code.*

FDA Label Image

Principal Display Panel (0.5 mL Syringe Carton)

Packaging label for Flublok Quadrivalent Influenza Vaccine 2022/2023 formula by Sanofi Pasteur. The label states it contains 10 single-dose prefilled syringes, each 0.5 mL, for intramuscular administration in adults 18 years and older. It includes storage instructions, manufacturer and distributor information, barcode, and warnings about syringe materials and no preservatives.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.